Kjetil Tasken

Adjunct Professor - Institute for Cancer Research
Image of Kjetil Tasken
Norwegian version of this page
Mobile phone +47 90860759
Room K03:010, 3rd floor, west
Username
Visiting address Ullernchausseen 70 Research Building (FOBY - Bygg K) 0372 Oslo
Postal address OUS, Rikshospitalet Postboks 4950 Nydalen 0424 Oslo

See also LinkedIn (see right column).

Scientific Interests

Immune regulation and cancer immunology, cancer precision medicine, cancer biology, cell signaling in health and disease, drug development, translational medicine and innovation.

Current positions

  • Head and Director, Institute of Cancer Research (ICR), Oslo Univ. Hospital (OUH)
  • Group Leader ICR, Dept. of Cancer Immunology
  • Professor of Medicine, University of Oslo (UiO) (since 2001, from 2018 at Institute for Clinical Medicine))

Previous positions and international research experience

2008-2018   Director and Professor, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, UiO 

2011-2017   Adjunct Senior Scientist, Dept. Infect. Dis., OUH

2003-2016   Director, Biotechnology Centre, UiO (merged into NCMM from 2017)

2001-2005   Chair and Professor, Faculty of Medicine Thematic Research Programme for Signal Transduction , UiO

2001-2010   Chief Scientific Officer, Lauras AS (adjunct position)

2001-2018  Professor I (full) at Institute for Basic Medical Sciences, UiO (Molecular Medicine, Biochemistry, on leave of absence to lead Biotechnology Ctr and NCMM 2003-18)

1998-2000   Senior Scientist and Group Leader, Inst. Basic Medical Sciences, UiO

1995-1997   Postdoctoral fellow, Inst. Med. Biochemistry, UiO                        

1994, 1998  Internships, Medicine, Surgery, General Practise

1988, 1993  Research stays University of California, San Diego, CA and  Université Laval, Quebec, Canada 

Research achievements and key leadership assignments

2019  Honorary Member, Norwegian Society for Immunology

2018  Faculty Medal, Faculty of Medicine for wise and outstanding leadership of NCMM

2018- NCMM Associate Investigator

2018-2022 Partner in K.G. Jebsen Centre for B cell malignancies

2018 Digitalis Purpurea Award by the Medical Faculty, UiO for outstanding scientific  leadership

2016  King Olav V’s Prize for Cancer Research (Life achievement award by Norwegian Cancer Soc.)

2013-17 Partner and Assistant Director in K.G. Jebsen Inflammation Research Centre 

2013-19 Partner in K.G. Jebsen Centre for Cancer Immunotherapy

2012  Chair of Gordon Research Conference on Cyclic nucleotide PDEs (vice chair 2010)

2010-19 EU-Openscreen, Norwegian Partner, Head, NOR-Openscreen nat. infrastructure chem. biol. 

2006-12 Organizer of 4 FEBS/EMBO/ESF Workshops on Spatiotemporal signaling, Oslo

2008  Elected member of ScanBalt Academy for Life Science

2008-18 EATRIS, Norwegian Partner / National Director, ESFRI project and ERIC

2008-17 Coordinator in one and Partner in three NordForsk grants

2006  Co-organizer of Nobel Symposium on the Adipocyte

2005 Elected member of The Norwegian Academy of Science and Letters

2005  Organizer ESF 2nd Mtg. on Functional Genomics and Disease, Oslo

2002-2015 Coordinator 2 EU FP6 RTD and STREP projects, partner 4 FP7 & 1 Hz2020 projects

2002  Recipient of the Anders Jahre Medical Award for Younger Scientists (Nordic Prize)

2002  King’s Gold Medal  to Line M. Grønning Wang for her Thesis (supervisor Kjetil Taskén)

2001-2007 Young Excellent Investigator Programme, Research Council of Norway (RCN).

Commissions of trust, selected

2019- OUH Research Committee (member), OUH Precision Medicine (member) & OUH Precision Cancer Medicine (chair) Committees 

2019-  Cancer Research UK’s New Agents Committee 

2018-  Scientific Council (vice-chair), Norwegian Cancer Society

2018- Scientific Advisory Board, PCI Biotech ASA

2017- Innovative Medicines Initiative (IMI) Scientific Committee (European Union)

2017- Associate Editor, Frontiers Immunol. (T cell biology) (Review Editor 2010-17)

2017-2021 Chair, SAB for Biocity Turku Biocenter and Turku Centre for Biotechnology

2016 Chair, SciLifeLab evaluation, panel 2 (Chem. Biol. & Drug Dev.)

2015, 2016  Chair, Academy of Finland Research Professorships Selection Panel

2014- Panel Member: ERC LS3 panel, Starting grants

2011- PLoS One Academic Editor

2011-  Scientific Advisory Board, Institute for Biomedical Technology, Tampere Finland

2003- Panel member in Evaluation panels in panels in Research Council of Norway, Swedish Research Council, Academy of Finland, EU, NIH National Cancer Institute.

2006- Grant Reviewer ERC, EU, Hfsp, Welcome Trust, CRUK and most natl. European Res agencies.

2006- Ad hoc reviewer for approx. 30 journals (25-30 papers/year).

2006-  More than 30 Selection Board Committees for positions in Norway, Sweden, Denmark, Finland. More than 25 Tenure and Promotion Reviews in UK, US, Switzerland a.o.

2006- More than 25 Ph.D.-evaluation committees in Norway, France, Sweden, Denmark, Finland

Communication of Science

Taskén has published more than 280 articles in peer-reviewed journals, which have been cited some 12,000 times in the literature (h-index 58). He has given more than 300 lectures and seminars, internationally and nationally, and his group's research has been described and featured in countless magazine and newspaper articles. Taskén has also published several popular press articles, as well as participated in numerous newspaper and radio interviews.

Tags: Cell signalling, Cancer, Cancer biology, Cancer research, Health, Immunology, Life sciences, Regulatory T cells, T cells, Precision Medicine, Personalised Medicine
Published Dec. 11, 2018 12:35 PM - Last modified Mar. 2, 2020 2:19 PM